Podcasts

Episode 91: The Newly Diagnosed Experience

When a person shows up in a doctor’s office with symptoms that may be related to Parkinson’s disease (PD), the diagnosis may not be obvious since symptoms often differ from person to person or could be indicative of other conditions. It’s not uncommon for people go from doctor to doctor over months or even years before they get a correct diagnosis. A visit to a movement disorders neurologist may result in a faster PD diagnosis, but unless PD is suspected, that may not be the first medical specialist on someone’s list.

For some, a Parkinson’s diagnosis comes as a relief; an explanation for previously unexplained symptoms. Others may be stunned, struggling with what the future may look like. As you begin processing your emotions, which can be wide-ranging, it’s important to know you are not alone. In this episode, Gretchen Rosswurm describes her experience with getting a PD diagnosis and how she dealt with it. One way was to take advantage of many of the resources of the Parkinson’s Foundation. Gretchen is now the Chair of the People with Parkinson’s Council of the Foundation. Certainly not everyone accepts or approaches a new PD diagnosis in the same way. So Anna Hedges relates some of the questions she has fielded from newly diagnosed callers as a Parkinson’s Foundation Helpline Information Specialist for the past ten years.

Released: October 6, 2020

Podcasts

Episode 193: Understanding REM Sleep Disorders in Parkinson's

Sleep problems affect more than 75% people with Parkinson’s disease (PD) and can have a significant impact on day to day life. Common challenges include difficulty falling or staying asleep, excessive sleepiness during the day, and acting out dreams while asleep. 

This episode focuses on REM (Rapid Eye Movement) Sleep Behavior Disorder, or RBD, a condition in which people may verbally and/or physically act out their dreams. These instances can increase the risk of injury for both the person with Parkinson’s and their bed partner, making awareness and symptom management especially important.

We invited Dr. Aleksandar Videnovic, Chief of the Division of Sleep Neurology at Massachusetts General Brigham, along with Caron Gan and John Poma, members of the NAPS Consortium on REM Sleep Behavior Disorders, to share insights on what RBD is, why it happens, and strategies for managing symptoms.

Key Takeaways:

  • Growing research shows that RBD can precede a Parkinson’s diagnosis by several years. 
  • RBD symptoms can change over time and may include physically and/or verbally acting out dreams. 
  • Sleep disturbances and fragmented sleep can contribute to fatigue and may worsen other PD symptoms. 
  • Practical Strategies:
    • Remove objects near the bed that may cause injury.
    • Lower the bed or mattress to reduce the risk of falls.
    • Create a consistent sleep schedule.
    • Keep a sleep diary to track symptoms and patterns.
    • Find an “RBD buddy” to share stories and tips.

Released: August 11, 2026

Science News

Early-Onset Parkinson’s in Younger Adults Is Rising Worldwide, Global Study Finds

🧠 What will you learn in this article?

This article highlights a new study published in npj Parkinson’s Disease that set out to assess how common early-onset Parkinson’s disease is around the world and whether that picture has changed over time. Highlights include:

  • Early-onset Parkinson’s disease (EOPD), diagnosed between ages 20 and 49, has become significantly more common worldwide, with cases more than doubling from 1990 to 2021.
  • The sharpest increases were seen among adults in their late 40s and in middle- and upper-middle-income regions, especially East Asia and Andean Latin America.
  • Researchers found associations between higher pesticide use and higher early-onset Parkinson’s rates, though the study does not prove cause and effect.
  • The findings show increased overall EOPD burden, highlighting the need for earlier recognition, more targeted research and support services designed for younger adults living with Parkinson’s.
Woman working from home with family in the background

Parkinson’s disease (PD) is often thought of as a condition that affects older adults — and most of the time, it does. But roughly 5% to 10% of people with Parkinson’s are diagnosed before age 50, a form of the disease known as early-onset Parkinson’s disease (EOPD).

Early-onset Parkinson’s carries a distinct set of challenges. People diagnosed in their 30s and 40s are often at the peak of their careers and raising families, and the disease can affect work, finances, relationships and mental health in ways that differ from a diagnosis later in life. Understanding how many people are affected — and how this varies across the world — is the first step toward directing research and resources to address the problem.

A new study published in npj Parkinson’s Disease set out to assess how common early-onset Parkinson’s is around the world and whether that picture has changed over time. Researchers in China analyzed three decades of data from the Global Burden of Disease Study 2021, a large international project that tracks hundreds of health conditions across 204 countries and territories. They estimated that between 1990 and 2021, the global burden of early-onset Parkinson’s more than doubled.

Study Results

Among adults ages 20 to 49, researchers investigated EOPD burden by looking at:

  1. New cases each year (incidence)
  2. The total number of people living with the disease (prevalence)
  3. Years lived with disability, a standard measure of how much a condition affects daily life

All three roughly doubled or more over the study period. New cases rose from about 28,000 per year in 1990 to about 81,000 in 2021. The total number of people living with early-onset Parkinson’s grew from roughly 190,000 to nearly 484,000.

Some of that increase reflects population growth — there are more people in the world than there were in 1990. But the researchers also calculated age-standardized rates, which adjust for population size and age structure. Those adjusted rates rose too, meaning early-onset Parkinson’s became more common, not just more numerous.

The rising rates were not spread evenly across the age range. Even among adults under 50, risk climbed sharply with each age bracket — people in their late 40s were diagnosed at dozens of times the rate of those in their early 20s. That pattern isn’t surprising, since Parkinson’s risk increases with age. But this oldest bracket also saw the fastest growth over the study period, meaning the rise in early-onset Parkinson’s is being driven largely by people in their late 40s.

The same adjusted rates also reveal that the increase was not evenly distributed worldwide. 

  • In 2021, rates were highest in Andean Latin America — Peru, Bolivia and Ecuador — followed by East Asia, particularly China. 
  • Of the 204 countries and territories studied, more than 170 showed rising rates, with the steepest growth in middle-income and upper-middle-income countries. 
  • Two countries with the fastest-rising rates were China and Norway. 
  • While most regions showed growth in EOPD rates, three regions were exceptions: high-income parts of North America, Central Europe and Central Asia. 

One pattern researchers noticed is that countries with heavier pesticide use per acre of farmland tended to have higher rates of early-onset Parkinson’s. Both Andean Latin America and China have large agricultural sectors with widespread pesticide use. This is a correlation across countries, not proof that pesticides caused these cases, but it lines up with existing research linking pesticide exposure to Parkinson’s risk.

That same idea — chemical exposure — may help explain another pattern in the data. Men had roughly 1.5 times the rates of women, and that gap has widened over time. The researchers suggest that men’s greater occupational exposure to pesticides, industrial chemicals and heavy metals may be one possible explanation, along with the potential protective effects of estrogen in women. 

Highlights

  • The global number of people diagnosed with early-onset Parkinson’s disease — between ages 20 and 49 — more than doubled between 1990 and 2021.
  • New cases rose from about 28,000 per year in 1990 to about 81,000 in 2021
  • People living with EOPD grew from about 190,000 to nearly 484,000.
  • More than 170 of 204 countries showed rising rates. High-income North America was an exception, with rates declining slightly.
  • The steepest growth in early-onset Parkinson’s occurred in middle-income countries, especially in East Asia and Andean Latin America.
  • Higher national pesticide use was associated with higher rates of early-onset Parkinson’s disease.
  • Men were diagnosed with early-onset Parkinson’s at about 1.5 times the rate of women.

What Does This Mean?

This study reminds us that Parkinson’s is not only a disease associated with aging; younger adults are also affected, and the number of younger adults living with it is growing worldwide. Given the earlier age of onset, those diagnosed with EOPD often experience the highest disease burden, spending many years living with PD. 

Accordingly, study authors noted that the increased burden of EOPD may reflect improvements in healthcare and better diagnosis— as health systems improve, more cases of EOPD get identified and recorded, and people live longer with the disease as treatments improve. However, the analysis also demonstrated a clear association between pesticide usage and rates of EOPD, indicating that PD remains closely linked with exposure to environmental contaminants even in younger adults.

Overall, the findings point to a need for earlier recognition of Parkinson’s in younger adults and for research and support services designed with this population in mind.

What Do These Findings Mean for People with Parkinson’s Right Now?

This study provides a global snapshot of the overall burden of early-onset Parkinson’s, not an explanation of what causes PD. However, these findings highlight that Parkinson’s can affect people at younger ages, reinforcing the importance of greater awareness of early- and young-onset PD. In addition, studies like this are needed to help influence policy decisions that ultimately improve the wellbeing of people living with PD. 

Earlier recognition of PD symptoms can help people seek care sooner, potentially leading to living better with PD in the long-term. The study also underscores the unique challenges many people with YOPD face, including managing careers, raising families and navigating financial responsibilities during some of the most active years of their lives.

Learn More

The Parkinson’s Foundation believes in empowering the Parkinson’s community through education. Learn more about early- and young-onset PD through our resources, or by calling our free Helpline at 1-800-4PD-INFO (1-800-473-4636) for answers to your Parkinson’s questions.

Advancing Research

From Golf Courses to Industrial Solvents: Meet the Researcher Investigating Parkinson's Risk

🧠 What will you learn in this article?

This article highlights a researcher studying how much and which kinds of pollutants increase Parkinson’s disease risk. It discusses: 

  • The research of Brittany Krzyzanowski, PhD, recipient of the Clinical Research Training Scholarship in Parkinson’s Disease
  • Which air pollutants are most linked to PD, and where they are most concentrated.
  • How living near a golf course could increase the risk of PD.
  • How this kind of research can guide future public health policies that reduce exposure to pollutants linked to PD.
Brittany Krzyzanowski headshot

Exposure to certain environmental contaminants is increasingly recognized as a risk factor for Parkinson’s disease (PD). Air quality plays a significant role in healthy living, and breathing in polluted air over time can lead to serious medical issues. Growing evidence suggests air pollution could be a risk factor in the development of Parkinson’s disease. However, air pollution comes in many forms from different sources, and it is not understood which types of air pollution are the greatest contributors to PD.

Brittany Krzyzanowski, PhD, is analyzing air quality information from across the U.S. to identify the high-risk pollutants associated with PD and where they are most concentrated. She recently completed this analysis as a recipient of the 2024 Clinical Research Training Scholarship in Parkinson’s Disease funded by the Parkinson’s Foundation and the American Brain Foundation, in collaboration with the American Academy of Neurology.

As a health geographer at the Atria Research Institute in New York City, Dr. Krzyzanowski uses her expertise in geospatial research to analyze environmental data to support prevention of future PD cases. Across the U.S., thousands of air quality monitoring stations, operated by federal, state, and local agencies, record the levels of various pollutants in the air.

“Since receiving the grant, I've been digging deeper into which specific air pollutants are most strongly linked to Parkinson's risk, and the picture is becoming clearer,” said Dr. Krzyzanowski. 

Dr. Krzyzanowski and her team used nationwide Medicare data and tested more than a dozen pollutants, including heavy metals, gases and different components of fine particulate matter (PM2.5) to see which were the strongest predictors of PD risk. 

“Two heavy metals — iron and vanadium — along with ozone showed the strongest associations, with weaker but still notable links to formaldehyde and a component of PM2.5 called sulfate. Because heavy metals and ozone are often tied to traffic and industrial emissions, these results point toward specific, modifiable sources of air pollution that public health efforts could target,” she said.

Dr. Krzyzanowski said her current research into air pollutants builds on two related studies that were recently published with the support of the Parkinson’s Foundation. 

Golf Study Findings

The first study, published in JAMA Network Open, found that older adults living within one mile of a golf course had more than double the odds of developing PD compared with people living more than six miles away, with the strongest associations in areas where drinking water came from vulnerable groundwater sources — suggesting pesticide runoff may play a role.

However, the proximity relationship persisted even after Dr. Krzyzanowski and her team accounted for groundwater vulnerability, and it was stronger in denser, urban areas, which points to airborne pesticide drift as a second, independent exposure route.

TCE Study Findings

In another study, published in Neurology, Dr. Krzyzanowski and team found that people living in areas with the highest levels of the industrial solvent trichloroethylene (TCE) had a higher risk of Parkinson's than those in the lowest-exposure areas. The highest TCE levels were concentrated in parts of the Northeast and Midwest, particularly the Rust Belt.

This information could guide future public health policies that reduce exposure to these pollutants, potentially decreasing the incidence of PD in vulnerable communities.

“Together, these studies reinforce a theme that's central to my research: Parkinson's risk isn't just about how much pollution someone is exposed to, but what kind,” said Dr. Krzyzanowski. “I think about this research as a bridge between data and action. It's not enough to say pollution is linked to Parkinson's risk.”

“Policymakers need to know which pollutants, at what levels, and where, so they can prioritize interventions that actually make a difference,” she said. “Whether that means tightening regulations on industrial solvents like TCE, rethinking pesticide use near residential areas or improving air quality monitoring in high-traffic corridors, my hope is that this work gives communities and decision-makers the specificity they need to act.”

Ready to take action? Visit our Advocacy Center to ask your representatives to support the federal ban on Paraquat, a dangerous chemical linked to PD that is still in use today. 

My PD Story

Gary Krajewski headshot
People with PD

Gary Krajewski

My Parkinsonism Story

In late 2018, an ear, nose and throat (ENT) physician noticed a resting tremor in my left hand, reduced left arm swing and a pill-rolling movement. After an MRI, I was initially diagnosed with Parkinson’s disease (PD), but the diagnosis was later revised to Parkinsonism/atypical Parkinsonian syndrome

My symptoms have included a mild left-hand tremor, reduced arm swing, lightheadedness, balance issues and some urinary symptoms, while remaining relatively stable over time. 

Parkinsonism is a set of movement symptoms associated with Parkinson’s and other disorders. It describes symptoms rather than a specific disorder.

Atypical Parkinsonism is a group of progressive brain disorders with some of the symptoms seen in PD. Symptoms are often more serious early on.

What has helped me!

After my diagnosis, I decided to focus on what I could do rather than what I had lost.

In 2024, I became a Parkinson’s Ambassador and helped launch a local PD Art & Music Night with support from Duke Health Movement Disorders Center, a Parkinson’s Foundation Center of Excellence. The event has grown successfully over multiple years. I am also involved with Moving Day and Parkinson’s Revolution fundraising efforts and began serving as a Board Member for the Parkinson’s Foundation Carolinas chapter in 2026. 

Managing Parkinsonism has centered on four daily priorities: exercise, speech, sleep and nutrition. I also maintain a daily art practice that helps me express my experiences living with Parkinsonism and supports others in the PD community. 

Advice

My advice for those newly diagnosed is to shift the question from “Why?” to “What?” Instead of asking why this happened, ask: 

What can I still do? 
What resources are available? 
What steps can I take today to live well? 

Focusing on those questions has helped me move forward with purpose and hope.

For me, it has been helpful to arrange Parkinson’s Foundation resources into a daily life survival kit. I believe that gives me a better perspective on WHAT I need every day.

Explore Parkinson’s Foundation resources today. 

Policy & Advocacy

Meet the Bill: The Paraquat Prevention Act

🧠 What will you learn in this article?

  • What the Paraquat Prevention Act would do
  • Why reducing paraquat exposure is a Parkinson’s prevention priority
  • Why bipartisan leadership matters
  • How you can raise the issue with Congress
Worker spraying toxic pesticides on plantation

One herbicide that has been linked to Parkinson’s disease (PD) is paraquat, a widely used commercial herbicide in the U.S. On June 18, Representatives Anna Paulina Luna, a Republican representing Florida, and Chellie Pingree, a Democrat representing Maine, introduced the Paraquat Prevention Act.

The bill would ban paraquat across the U.S. People who live or work near where paraquat is sprayed have a higher risk of developing Parkinson’s. If passed, this bill would protect farmers, farmworkers, rural families and other communities from unnecessary exposure.

What would the Paraquat Prevention Act do?

The Paraquat Prevention Act would: 

  • Require the Environmental Protection Agency to cancel the approvals that allow paraquat to be used
  • Implement a zero-tolerance policy for paraquat residue on food
  • Stop the sale and use of paraquat already in stock
  • Prevent paraquat from being approved for future use

Together, these steps would remove paraquat from the U.S. market and protect people regardless of where they live or work.

How can banning Paraquat impact Parkinson’s prevention?

Researchers are still working to better understand what causes Parkinson's, but growing scientific evidence links exposure to paraquat to an increased risk of developing the disease.

One study found that people who sprayed paraquat were more than twice as likely to develop Parkinson's as people who applied other pesticides. Although paraquat has been banned in more than 70 countries, it remains available for agricultural use in the U.S.

Not everyone exposed to paraquat will develop Parkinson's. However, reducing exposure to preventable environmental risks is one way public policy can help create a future where fewer people develop Parkinson's.

“By banning paraquat, the Paraquat Prevention Act would protect Americans and help create a world where fewer people develop Parkinson’s disease in the first place.”

— Andi Lipstein Fristedt, Parkinson’s Foundation Chief Strategy and Policy Officer

Preventing harmful toxic exposures is a public policy priority for the Parkinson’s Foundation. 

Explore more Parkinson's Foundation policy priorities that focus on research, care, prevention and education. 

Building on Progress in the States

States have begun taking action. In May, Vermont became the first state in the country to ban paraquat after advocacy from the Parkinson’s community and other public health groups. Thirteen other states have considered similar proposals this year, with MichiganNew Jersey and Pennsylvania still ongoing.

State action can protect individual communities and build momentum, but a federal ban would provide the same protection to people nationwide.

Support Extends Across Party Lines

Representatives Luna and Pingree come from different political parties and represent different parts of the country. Their partnership reflects the growing recognition that protecting people from harmful environmental exposures should not be a partisan issue.

Voters agree. A national survey found that 67% of registered voters supported banning or limiting paraquat after learning that research has linked it to Parkinson’s. Support increased to 81% after voters learned more about potential exposure risks.

This broad support provides a strong foundation for lawmakers from both parties to come together around the bill.

Help Build Support While Congress Is Home

Introducing a bill is just the first step. It takes public support to build momentum and move legislation forward.

While Congress is in recess this August, members of Congress will return home to meet with constituents at town halls and community events. These meetings are an opportunity to share your Parkinson's story and ask one simple question: Will you support and cosponsor the Paraquat Prevention Act to ban paraquat nationwide? 

Our Advocacy Center has everything you need to find an event, prepare your story and make your voice heard. Not able to attend an event? Join the Parkinson’s Foundation Advocacy Network to receive policy updates and future opportunities to contact Congress.

Fundraising Events

2027 Double TCS London Marathon

6:00 am to 6:00 pm EST
A family smiling at the camera after a Champion's event by the ocean.

The Parkinson's Foundation is an official charity partner for the 2027 Double TCS London Marathon with bibs available for the SATURDAY part of the event. By signing up to run as a Parkinson's Champion you commit to raising funds and awareness for the Parkinson's Foundation, and in return you get access to a free entry (bib) to the race in addition to tons of other fun benefits and perks. You can learn more about our program and join our interest list at Run4PD.org.

Fundraising Commitments:
•    VIP - $10,000
•    Marathon - $5,000
•    Honorary Champion - $500

From Greenwich to The Mall – the sights, sounds and colours of London on Marathon Day make the 26.2-mile route one of the world’s best. Roaring crowd support, dozens of cheer zones, live bands and DJs turn the city into one big marathon party. Throw in famous landmarks and a picture-perfect finish and it’s easy to see why this is the bucket-list marathon. The TCS London Marathon is one of the Abbott World Marathon Majors, so this could be the start of your six-star journey!

If you have questions, send us an email at Run4PD@Parkinson.org. For more information about the race itself, visit the London Marathon Homepage.
 

Upcoming Events

Fundraising Events

2026 Falmouth Road Race

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Falmouth, MA
Educational Events

Mind, Mood, and Motion

10:00 am to 3:00 pm PDT
Free
Mind Mood and Motion Banner Updated

Exercise is a powerful tool for managing Parkinson’s disease symptoms at every stage. This program explains how staying active supports movement, mood, and thinking- and may even slow disease progression. Participants will learn practical ways to build exercise into daily life for better mobility and overall well-being.

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends, and the community.

Upcoming Events

Fundraising Events

2026 Falmouth Road Race

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Falmouth, MA
Educational Events

Cómo identificar y gestionar los riesgos de caídas con la EP

Virtual ( Zoom )
1:00 pm to 2:00 pm EST
Gratis
Una pareja mirando una tableta juntos en su porche

Regístrese Aquí

Las caídas son una preocupación habitual para las personas que viven con la enfermedad de Parkinson (EP) y pueden tener un impacto significativo en la seguridad, la confianza y la participación. En este programa, exploraremos cómo el Parkinson afecta la marcha (caminar), el equilibrio y las maneras de reconocer los factores motores y no motores que pueden aumentar el riesgo de caídas. Los expertos compartirán estrategias prácticas para mejorar la seguridad y minimizar el riesgo de caídas, y así facilitar el equilibrio y la movilidad en la vida cotidiana.
 

10 a.m. hora del Pacífico (California)
11 a.m. hora de la Montaña (Colorado, Phoenix y Nuevo México)
12 p.m. hora del Centro (Texas y Ciudad de México)
1 p.m. hora del Este (Nueva York , Peru y Colombia)
2 p.m. hora de Venezuela
3 p.m. hora de Chile y Argentina
7 p.m. hora de España

*Por favor, verifica su zonas horarias.*

Presentadora

Ana Sanchez Junkin, DPT
Fisioterapeuta
Massachusetts General Hospital 

¿Busca algo más? Podrá encontrar todos nuestros videos de EP Salud en Casa en YouTube.


Más información:

Todos los eventos de “EP Salud en Casa" – Parkinson.org/EPSalud.

Una lista de nuestros recursos en español – Parkinson.org/Recursos

Línea de Ayuda – 1-800-473-4636, opción 3 para español.

EP Salud En Casa es presentado por Light of Day Foundation, cuya generosidad ha hecho posible esta programación.

Light of Day

Upcoming Events

Fundraising Events

2026 Falmouth Road Race

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Falmouth, MA
Educational Events

Learn More. Live Better. Parkinson's Symposium

9:00 am to 1:30 pm CDT
FREE
Learn More. Live Better. Parkinson's Symposium banner

Living with Parkinson's can be challenging, but there are many things you can do to maintain and improve your quality of life. This program will provide you with information to help you find the balance between a proactive approach and wondering what lies ahead.

Event Overview:

9:00 a.m. CT - Check-in & Resource Fair
10:00 a.m. CT - Program begins
1:30 p.m. CT - Program end

Lunch will be served for all attendees.


There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their families, friends, and the community.

Upcoming Events

Fundraising Events

2026 Falmouth Road Race

Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular races. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon.

Falmouth, MA
Back to Top